Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it is transferring the U.S. listing of its global shares to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. The transfer to the NYSE is expected to be effective on or about January 10, 2018. QIAGEN’s […]
London, UK — Copenhagen Center for Glycomics (CCG) and Desktop Genetics (DTG) today announced a collaboration to develop the next-generation of CRISPR analysis. The project is designed to provide a deeper understanding of a novel method of identifying nuclease-generated mutations developed by the lab of Dr. Eric Paul Bennett. The method is currently used by CCG and […]
Bertin’s Precellys® Evolution Homogenizer and Zymo Research’s ZymoBIOMICS® Microbial Community Standard: Liberation of DNA From all Microbes in Just One Minute IRVINE, Calif. & ROCKVILLE, Md.–Zymo Research Corp. and Bertin announce a collaboration that ensures the sample lysis step in the microbiome workflow is complete and unbiased. An application note is available describing the materials, procedure and results attained […]
Oncomine Myeloid Research Assay leverages Thermo Fisher’s next-generation sequencing to analyze 74 genes in a single panel and overcome hurdles of sequential-based clinical research CARLSBAD, Calif. — Clinical researchers interested in studying driver mutations suspected in hematological malignancies now have access to a new targeted next-generation sequencing (NGS) research panel for simultaneous analysis of 74 relevant genes. […]
SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with Caltag Medsystems Ltd. to distribute and market StemBioSys products. Caltag will distribute StemBioSys products in the European Union. Initially, the agreement will cover StemBioSys’ cell expansion products, but as additional products are added to StemBioSys’ portfolio in the future, these […]
The proposed national coverage determination provides Medicare beneficiaries with reimbursable testing using multi-biomarker NGS IVD tests to better inform treatment decisions CARLSBAD, Calif. — The Centers for Medicare & Medicaid Services (CMS) has proposed coverage for the Oncomine Dx Target Test as part of a national coverage determination (NCD) for next-generation sequencing (NGS) in vitro diagnostic (IVD) tests. Once […]
Zurich / Glattbrugg | Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, announce their partnership. Thanks to this partnership, JPK’s NanoWizard® AFM users will now be […]
SHENZHEN, China, CAMBRIDGE, Mass. and SHERMAN OAKS, Calif. — BGI Genomics, a global leader in Next Generation Sequencing Services, and Sanguine BioSciences, Inc., a builder of data-integrated patient communities, have joined forces to develop a database of combined genomic and clinical data to increase the speed and efficiency of Precision Clinical Trial Recruitment. For their […]
– TruePrime™ cfDNA kit offers superior selectivity and preferential amplification – Liquid biopsy market is a fast-growing multibillion market – TruePrime™ cfDNA is fully scalable from small to mid-scale programs Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, […]
SHENZHEN, HEIDELBERG – BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbird Diagnostics GmbH, Heidelberg, Germany, an innovator in miRNA-based diagnostic tests from blood for early disease detection, today announced that they have signed a Memorandum of Understanding (MoU) intending to establish a broad collaboration in miRNA-based […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
